NVAX FY 2010 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena

NVAXNovavax, Inc.

$2B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$343,000+5.5% YoY

Gross Profit

$343,000100.0% margin

Operating Income

-$38M-11222.7% margin

Net Income

-$36M-10410.5% margin

EPS (Diluted)

$-6.82

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$34M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$75M

Total Liabilities

$16M

Stockholders' Equity

$59M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$343,000	$325,000	+5.5%
Gross Profit	$343,000	$325,000	+5.5%
Operating Income	-$38M	-$37M	-3.0%
Net Income	-$36M	-$38M	+6.9%